In depth: Has the US succeeded in its OTC reforms?

The bulk of the Dodd-Frank reforms were implemented last year. Now it is Europe's turn. Is there anything Europe can learn from across the Atlantic?


Those involved in the US derivatives market were likely to have ended 2013 breathing a deep sigh of relief, and congratulating themselves on making it through an extraordinary 12 months of regulatory change. After more than two years of rule-making by multiple US regulatory agencies, last year saw the bulk of the Dodd-Frank reforms rolled out – from mandatory trade reporting and clearing, to far-reaching external business conduct standards, to the controversial swap execution facility (Sef)

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here